Why the study?
Does transcatheter aortic valve implantation in a surgical aortic valve improve symptoms and hemodynamics in a patient with bioprosthetic valve degeneration?
Population
1 76-year-old male with a history of stage III hypertension, compensated type 2 diabetes, and aortic valve…
Design
Case_report
Follow-up
1 month
Key result
Transcatheter aortic valve implantation within a degenerated surgical aortic valve successfully alleviated dyspnea and improved cardiac function in a 76-year-old male.
Authors
Loading...
Supports valve-in-valve TAVI feasibility in high-risk bioprosthetic failure; leaves open durability and outcomes questions pending higher-level evidence.
Case Report (n=1)
No
Does transcatheter aortic valve implantation in a surgical aortic valve improve symptoms and hemodynamics in a patient with bioprosthetic valve degeneration?
Transcatheter aortic valve implantation within a degenerated surgical bioprosthesis is a feasible and effective minimally invasive treatment option that improves symptoms and hemodynamics, even in resource-limited settings.
Morales et al. (2024) conducted a case report in Severe aortic valve stenosis (bioprosthetic valve degeneration) (n=1). Transcatheter aortic valve implantation (TAVI in SAVR) was evaluated on Clinical and echocardiographic improvement. Transcatheter aortic valve implantation within a degenerated surgical aortic valve successfully alleviated dyspnea and improved cardiac function in a 76-year-old male.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: